Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Biogen revenue, profit up in Q1
Bizjournals.com
Thursday, April 21, 2011 - 9:50am
tags:
Biogen Idec, earnings
Depomed: Light-Risk Small Pharma With Huge Potential
Seeking Alpha
Thursday, April 21, 2011 - 9:49am
tags:
Depomed
New generics quickly grab 80% of sales volume
Fierce Pharma
Thursday, April 21, 2011 - 9:25am
tags:
prescription data, generics
Roche's Genentech Sues Novartis Unit Claiming Infringement of Valcyte Drug
Bloomberg
Thursday, April 21, 2011 - 9:23am
tags:
Genentech, Novartis, Valcyte, generics, patents, AIDS
Merck, Vertex Prep for Hep C Drug Panels
TheStreet.com
Thursday, April 21, 2011 - 9:21am
tags:
Merck, Vertex Pharmaceuticals, hepatitis C, FDA, Boceprevir, Telaprevir, advisory panels
Pfizer, Shanghai Pharma Agree to Explore China Cooperation
Bloomberg
Thursday, April 21, 2011 - 9:19am
tags:
Pfizer, China, Shanghai Pharmaceutical
Gilead Q1 profit dips to $651.1M
Bizjournals.com
Wednesday, April 20, 2011 - 7:07pm
tags:
earnings, Gilead Sciences
Amgen Beats on Top and Bottom Lines, but Shares Drop
Bizjournals.com
Wednesday, April 20, 2011 - 7:00pm
tags:
Amgen, earnings
Dynavax gets $6M for start of human tests of lupus treatment
Bizjournals.com
Wednesday, April 20, 2011 - 6:55pm
tags:
lupus, GSK, Dynavax, DV1179
Turnaround at Johnson & Johnson? Let's Do Some Math.
Motley Fool
Wednesday, April 20, 2011 - 6:54pm
tags:
JNJ
CROs scramble as Big Pharma lines up strategic partnerships
Fierce Biotech
Wednesday, April 20, 2011 - 12:20pm
tags:
CROs, Big Pharma, R&D, Covance, PPD, Parexel, Charles River Laboratories, ICON, Kendle, Quintiles
J&J defends executive pay to institutional investors
Fierce Pharma
Wednesday, April 20, 2011 - 12:07pm
tags:
JNJ, executive pay
Gilead Sciences signs licensing deal with MicroDose for potential respiratory virus drug
Yahoo/AP
Wednesday, April 20, 2011 - 12:06pm
tags:
Gilead Sciences, RSV, MicroDose Therapeutx, MDT-637
Elan turns 1Q profit as Tysabri sales rise
Yahoo/AP
Wednesday, April 20, 2011 - 12:04pm
tags:
Elan, earnings
FDA approves Genentech vasculitis treatment
Bizjournals.com
Wednesday, April 20, 2011 - 12:04pm
tags:
FDA, Genentech, vasculitis, Rituxan
Lilly Will Pay Investors For Patience
Investopedia
Wednesday, April 20, 2011 - 12:02pm
tags:
invesors, Eli Lilly
Mylan now selling generic version of Novartis' herpes drug Famvir
Yahoo/AP
Wednesday, April 20, 2011 - 12:01pm
tags:
Mylan, generics, Famvir, Novartis, herpes zoster
Sangamo Biosciences's Game Changing Technology
Seeking Alpha
Wednesday, April 20, 2011 - 9:57am
tags:
Sangamo BioSciences, ZFP technology
U.S. Backs Roche Cervical Cancer Test
WSJ Online
Wednesday, April 20, 2011 - 9:56am
tags:
Roche, cervical cancer
Is BioSante Giving Away the Store?
Motley Fool
Wednesday, April 20, 2011 - 9:55am
tags:
BioSante, Aduro BioTech, pancreatic cancer, prostate cancer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.